REGULATION OF CHOLANGIOCYTE PROLIFERATION BY THE miR-125B/HDC/HA/VEGF AXIS IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS

被引：0
|
作者：
Han, Y. [1 ]
Meng, F. [2 ]
Hargrove, L. [1 ]
Graf, A. [2 ]
Kennedy, L. [2 ]
Francis, H. [1 ,2 ]
机构：
[1] Scott & White Healthcare & Texas A&M Hlth Sci Ctr, Temple, TX USA
[2] Cent Texas Vet Hlth Care Syst, Temple, TX USA
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60510-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P348
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [1] Role of the miR-125b-regulated HDC/histamine/VEGF axis during the progression of biliary proliferation in the PSC/MDR2-/- mouse model
    Han, Yuyan
    Hargrove, Laura
    Kennedy, Lindsey
    Graf, Allyson B.
    DeMorrow, Sharon
    Meng, Fanyin
    Nguyen, Quy P.
    Huynh, Victoria
    Francis, Heather L.
    HEPATOLOGY, 2014, 60 : 338A - 339A
  • [2] miR-125b targets l-histidine decarboxylase (HDC) and inhibition of HDC decreases biliary proliferation, VEGF signaling and hepatic fibrosis in Mdr2-/- mice
    Demieville, Jennifer
    Hargrove, Laura
    Kennedy, Lindsey
    Jones, Hannah
    Smith, Steven
    Stephenson, Kristen
    Meng, Fanyin
    Francis, Heather L.
    HEPATOLOGY, 2017, 66 : 212A - 212A
  • [3] 4-METHYLUMBELLIFERONE IMPROVES LIVER STIFFNESS, CHOLANGIOCYTE PROLIFERATION AND FIBROSIS IN THE Mdr2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Kunimoto, Koshi
    Fan, Weiguo
    Li, Yuan
    Dehnad, Ali
    Mozes, Gergely
    Wang, Yanan
    Nagy, Nadine
    Bollyky, Paul
    Torok, Natalie J.
    HEPATOLOGY, 2021, 74 : 740A - 741A
  • [4] The gut-liver axis is essential for disease progression in the Mdr2-/- mouse model of primary sclerosing cholangitis
    Liao, L.
    Schneider, K. M.
    Frissen, M.
    Strowig, T.
    Marschall, H. -U.
    Wahlstroem, A.
    Eric, G.
    Mohs, A.
    Jin, P.
    Jung, J.
    Reissing, J.
    Sun, H.
    Elfers, C.
    Bieghs, V.
    Cubero, F. J.
    Trautwein, C.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S6 - S6
  • [5] MiR-200b Modulates Angiogenesis and Liver Fibrosis in the Mdr2-/- Model of Primary Sclerosing Cholangitis
    Kyritsi, Konstantina
    Meng, Fanyin
    Venter, Julie
    Francis, Heather L.
    Wu, Nan
    Gaudio, Eugenio
    Franchitto, Antonio
    Onori, Paolo
    Hall, Chad
    Standeford, Holly
    Alpini, Gianfranco
    Glaser, Shannon
    GASTROENTEROLOGY, 2016, 150 (04) : S1021 - S1021
  • [6] The melatonin/MT1/miR-200b axis regulates biliary senescence and liver fibrosis in the Mdr2-/- mouse model of primary sclerosing cholangitis
    Wu, Nan
    Meng, Fanyin
    Invernizzi, Pietro
    Venter, Julie
    Bernuzzi, Francesca
    Alvaro, Domenico
    Onori, Paolo
    Franchitto, Antonio
    Zhou, Tianhao
    Francis, Heather L.
    Kyritsi, Tina
    Mancinelli, Romina
    Gaudio, Eugenio
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2016, 64 : 178A - 178A
  • [7] Mdr2-p-glycoprotein-deficient (Mdr2-/-) mouse - A new model for primary sclerosing cholangitis (PSC)?
    Fickert, P
    Fuchsbichler, A
    Zollner, G
    Stumptner, C
    Weiglein, A
    Zatloukal, K
    Denk, H
    Trauner, M
    HEPATOLOGY, 2001, 34 (04) : 509A - 509A
  • [8] Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation
    Baghdasaryan, Anna
    Claudel, Thierry
    Kosters, Astrid
    Gumhold, Judith
    Silbert, Dagmar
    Thueringer, Andrea
    Leski, Katharina
    Fickert, Peter
    Karpen, Saul J.
    Trauner, Michael
    GUT, 2010, 59 (04) : 521 - 530
  • [9] Melatonin Therapy Reduces Biliary Proliferation and Hepatic Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis (PSC) By Decreased Expression of miR-200b and Angiogenic Factors
    Wu, Nan
    Meng, Fanyin
    Venter, Julie
    Francis, Heather L.
    Standeford, Holly
    DeMorrow, Sharon
    Franchitto, Antonio
    Onori, Paolo
    Gaudio, Eugenio
    Alpini, Gianfranco
    Glaser, Shannon
    GASTROENTEROLOGY, 2016, 150 (04) : S1046 - S1046
  • [10] Inhibition of hepatic senescence decreases biliary proliferation and liver fibrosis in vitro and in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC).
    Kyritsi, Tina
    Zhou, Tianhao
    Meng, Fanyin
    Wu, Nan
    Venter, Julie
    Giang, Thao
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2017, 66 : 109A - 109A
12345